Blood tests to predict bladder medication response in women
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether simple blood tests can predict how well a woman with overactive bladder will respond to the medication mirabegron (also called Myrbetriq). If successful, doctors may be able to choose the right treatment earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have had overactive bladder symptoms (like sudden urge to urinate) for at least 3 months.
- Your doctor has already decided to start you on mirabegron 50 mg as part of your normal care.
- You have not had any prior overactive bladder treatments (except behavioral therapy like bladder training).
- You have no active infections, chronic inflammatory diseases, or other bladder conditions that could affect the results.
- You are not pregnant or breastfeeding, and you have no major health issues like severe kidney or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two pills (solifenacin and mirabegron) for treating overactive bladder. It aims to see which works better and has fewer side effects. You may qualify if you're newly diagnosed and haven't tried these medicines before.
This study looks at the bacteria in the bladders of women with overactive bladder who are getting Botox injections. It aims to understand how these bacteria might affect treatment results.
This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.
This trial tests a new procedure that uses radiofrequency energy to calm the nerve responsible for overactive bladder in women. It aims to reduce urge-related urine leaks without surgery or medications.
This study tests a new treatment, TRG-200 KIT, given directly into the bladder for people with overactive bladder (OAB) that hasn't improved with other medications. It may help reduce urgency, frequent urination, and nighttime bathroom trips.
This study tests a new bladder treatment called NT 201 combined with a device called the Vibe System for women with overactive bladder (frequent, urgent need to urinate). The treatment is injected directly into the bladder and may help reduce urgency and leaking.
Hear when a new Overactive Bladder (OAB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.